The striopallidal pathway is involved in antiparkinsonian-like effects of the blockade of group I metabotropic glutamate receptors in rats

Neuroscience Letters

Volumn 342, Issue 1-2, 2003, Pages 21-24

  Ossowska, Krystyna ^a   Wardas, Jadwiga ^a   Pietraszek, Małgorzata ^a   Konieczny, Jolanta ^a   Wolfarth, Stanisław ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

(RS) 1 aminoindan 1,5 dicarboxylic acid; Group I metabotropic glutamate receptors; Haloperidol; Parkinsonism; Proenkephalin mRNA; Rat; Striopallidal pathway

Indexed keywords

1 AMINO 1,5 INDANDICARBOXYLIC ACID; ANTIPARKINSON AGENT; HALOPERIDOL; MESSENGER RNA; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR ANTAGONIST; NEUROPEPTIDE; PROENKEPHALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALEPSY; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG MECHANISM; GABAERGIC SYSTEM; GLOBUS PALLIDUS; MALE; NONHUMAN; PARKINSONISM; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; TISSUE DISTRIBUTION;

EID: 0037448018     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00221-0     Document Type: Article

References (24)

1. Angulo J.A. Involvement of dopamine D1 and D2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain. J. Neurochem. 58:1992;1104-1109.
2. Beckstead R.M. N-Methyl-D-aspartate acutely increases proenkephalin mRNA in the rat striatum. Synapse. 21:1995;342-347.
3. Chapman M.A., See R.E. Differential effects of unique profile antipsychotic drugs on extracellular amino acids in the ventral pallidum and globus pallidus of rats. J. Pharmacol. Exp. Ther. 277:1996;1586-1594.
4. Drew K.L., O'Conor W.T., Kehr J., Ungerstedt U. Regional specific effects of clozapine and haloperidol on GABA and dopamine release in rat basal ganglia. Eur. J. Pharmacol. 187:1990;385-397.
5. Dziedzicka-Wasylewska M., Rogo R. The effect of prolonged treatment with imipramine and electroconvulsive shock on the levels of endogenous enkephalins in the nucleus accumbens and the ventral tegmentum of the rat. J. Neural Transm. 102:1995;221-228.
6. Gerfen C.R. Molecular effects of dopamine on striatal-projection pathways. Trends Neurosci. 23:(Suppl.):2000;S64-S70.
7. Grimm J.W., See R.E. Chronic haloperidol-induced alterations in pallidal GABA and striatal D(1)-mediated dopamine turnover as measured by dual probe microdialysis in rats. Neuroscience. 100:2000;507-514.
8. Jolkkonen J., Jenner P., Marsden C.D. Glutamatergic regulation of striatal peptide gene-expression in rats. J. Neural Transm. 10:1995;187-198.
9. Kita H. Glutamatergic and GABAergic postsynaptic responses of striatal spiny neurons to intrastriatal and cortical stimulation recorded in slice preparation. Neuroscience. 70:1996;925-940.
10. Leveque J.C., Macias W., Rajadhyaksha A., Carlson R.R., Barczak A., Kang S., Li X.M., Coyle J.T., Huganir R.L., Heckers S., Konradi C. Intracellular modulation of NMDA receptor function by antipsychotic drugs. J. Neurosci. 20:2000;4011-4020.
11. Lorenc-Koci E., Wolfarth S., Ossowska K. Haloperidol-induced muscle tone in rats as a model of parkinsonian rigidity. Exp. Brain Res. 109:1996;268-276.
12. Mao L., Wang J.Q. Selective activation of group I metabotropic glutamate receptors upregulates preprodynorphin, substance P, and preproenkephalin mRNA expression in rat dorsal striatum. Synapse. 39:2001;82-94.
13. Moroni F., Lombardi G., Thomsen C., Leonardi P., Attucci S., Peruginelli F., Torregrossa S.A., Pellegrini-Giampietro D.E., Luncia R., Pellicciari R. Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent mGluR1 antagonist. J. Pharmacol. Exp. Ther. 281:1997;721-729.
14. Noailles P.A., Villegas M., Ledoux M., Lucas L.R., McEwen B.S., Angulo J.A. Acute treatment with the N-methyl-D-aspartate receptor antagonist MK-801: effect of concurrent administration of haloperidol or scopolamine on preproenkephalin mRNA levels of the striatum and nucleus accumbens of the rat brain. Neurosci. Lett. 202:1996;165-168.
15. Ossowska K., Karcz-Kubicha M., Wardas J., Kre A., Wolfarth S. Zona incerta-lateral hypothalamus as an output structure for impulses involved in neuroleptic drug-induced catalepsy. Naunyn-Schmiedeberg's Arch. Pharmacol. 347:1993;415-420.
16. Ossowska K., Konieczny J., Pilc A., Wolfarth S. The striatum as a target for anti-rigor effects of an antagonist of mGluR1, but not an agonist of group II metabotropic glutamate receptors. Brain Res. 950:2002;88-94.
17. Ossowska K., Konieczny J., Wolfarth S., Wieronska J., Pilc A. Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats. Neuropharmacology. 41:2001;413-420.
18. Ossowska K., Wedzony K., Wolfarth S. The role of the GABA mechanisms of the globus pallidus in mediating catalepsy, stereotypy and locomotor activity. Pharmacol. Biochem. Behav. 21:1984;825-831.
19. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, San Diego, CA.
20. Pisani A., Gubellini P., Bonsi P., Conquet F., Picconi B., Centonze D., Bernardi G., Calabresi P. Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons. Neuroscience. 106:2001;579-587.
21. Somers D.L., Beckstead R.M. N-Methyl-D-aspartate receptor antagonism alters substance P and met5-enkephalin biosynthesis in neurons of the rat striatum. J. Pharmacol. Exp. Ther. 262:1992;823-833.
22. Tallaksen-Greene S.J., Kaatz K.W., Romano C., Albin R.L. Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons. Brain Res. 780:1998;210-217.
23. Turski L., Havemann U., Kuschinsky K. GABAergic mechanisms in mediating muscular rigidity, catalepsy and postural asymmetry in rats: differences between dorsal and ventral striatum. Brain Res. 322:1984;49-57.
24. 3H]dopamine through a chronic cannula to produce rotation: distribution and concentration of the tracer in specific brain regions. Brain Res. 261:1983;205-212.